China unveils system for postmarket medical-device monitoring

09/10/2008 | FDAnews

China's State Food and Drug Administration has issued a white paper detailing the government's system for tracking adverse events linked to medical devices. Under the system, 10 national centers are in charge of registration testing of imported products and domestic products with Class III classification.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC